arrow drop search cross

TherAchon, the start-up born out of Université Côte d'Azur laboratories, acquired by Pfizer for 340 million dollars

TherAchon, a start-up created in 2014 by Elvire Gouze, Inserm researcher at the Valrose Institute of Biology, is developing innovative therapies to restore growth and normal bone proportion in children with dwarfism. The company was recently purchased by the pharmaceutical giant Pfizer for 340 million dollars. An exceptional success for a company whose scientific management is still located in the research buildings of Université Côte d'Azur.

How do Université Côte d'Azur researchers contribute to the sustainable development goals?

Université Côte d'Azur, the French National Research Institute for Sustainable Development (IRD) and the Côte d'Azur Regional Delegation of the CNRS met for a workshop in Sophia Antipolis on March 22, 2019, to reflect on the contribution to the Sustainable Development Goals (SDGs) of Université Côte d'Azur's research programs and of the Villefranche-sur-Mer oceanography laboratory.

Bacterial food contamination : researchers from Université Côte d'Azur make an essential discovery that improves understanding of the infectious mechanisms of bacteria

Recent news has demonstrated once again that food poisoning can be fatal. The World Health Organization predicts that more people will die from bacterial infections in 2050 than from cancer, especially now that bacteria are becoming more and more resistant to antibiotic treatment. This makes it essential to gain a better understanding of the infectious mechanisms of bacteria. The Department of Medical Biology of the Monaco Scientific Center and physicists of the Université Côte d'Azur's mathematics laboratory have taken a major step towards understanding the infectious mechanisms of bacteria and especially those responsible for food poisoning.

Université Côte d'Azur selected to set up an Interdisciplinary Institute for Artificial Intelligence

The 3IA Côte d'Azur project to create an Interdisciplinary Institute for Artificial Intelligence (3IA), led by Université Côte d'Azur, the CNRS and Inria was selected by the international jury on April 24 as part of the national program for artificial intelligence.

Yukin Therapeutics, a biotech start-up and offshoot of the Université Côte d'Azur's research, fights cancers

The teams of Thierry Passeron and Rachid Benhida have developed a new therapeutic strategy to boost the effectiveness of immunotherapy in fighting certain types of cancers. This major innovation is protected by two patents, owned jointly by the Université Côte d'Azur, the Inserm, the CNRS and the Nice University Hospital Center, which were recently granted by SATT Sud-Est (a Technology Transfer Accelerator in South-East France) to the young pharmaceutical start-up Yukin Therapeutics.

TherAchon, the start-up born out of Université Côte d'Azur laboratories, acquired by Pfizer for 340 million dollars
How do Université Côte d'Azur researchers contribute to the sustainable development goals?
Bacterial food contamination : researchers from Université Côte d'Azur make an essential discovery that improves understanding of the infectious mechanisms of bacteria
Université Côte d'Azur selected to set up an Interdisciplinary Institute for Artificial Intelligence
Yukin Therapeutics, a biotech start-up and offshoot of the Université Côte d'Azur's research, fights cancers